CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
PCaVision is an innovative prostate cancer imaging diagnostic method that utilizes modern ultrasound technology and advanced signal processing. It aims to improve patient access to diagnosis, reduce costs, and eliminate the need for specialized radiologists, making it a more efficient alternative to traditional biopsy…
Prostate cancer (PCa), is a type of cancer with the highest incidence (19%) and second mortality rate (8%) in western men.
In 2018 in Europe, 140,000 male patients were newly diagnosed with PCa and over 100,000 patients have died from Prostate cancer.
Numbers are rising due to the ageing EU population.The present medical diagnosis procedures are largely based on the execution of multi-biopsy procedure(s) on the patient.
Each multi-biopsy procedure is invasive, painful for the patient and incurs…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
